Inventor
STEPHEN EDWARD RAPECKI
Inventor
GB
Overview
Patents· 8 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes23%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations23%
C07KPeptides23%
G01NInvestigating or analysing materials by determining their chemical or physical properties13%
C07DHeterocyclic compounds10%
A01KAnimal husbandry6%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms3%
PatentTitleYear
12,474,348Complexes between CD40 and compounds comprising benzimidazole moieties202512,331,117Antibody molecules which bind CD22202511,692,041Antibody molecules which bind CD45202311,674,967Method of identifying potential inhibitors of APO TNFa trimers202311,472,879Antibody molecules which bind CD22202211,466,324Lipocalin 2 as a biomarker for IL-17 inhibitor therapy efficacy202211,448,655Method for identifying a modulator of the TNFa or CD40L interaction with their cognate receptors202211,261,252Molecules with specificity for CD79 and CD222022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to UCB Biopharma SRL (8)· patent assignee history
2022–2023Patents assigned to UCB BIOPHARMA SPRL (2)· patent assignee history
2022–2025Based in GB· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UCB Biopharma SRL | 8 | 2022–2025 |
| UCB BIOPHARMA SPRL | 2 | 2022–2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| GB | 8 | 2022–2025 |